3 Undervalued Software Stocks Set to Jump in 2024

These software stocks are overdue for a recovery, and that should certainly happen as they move back to profit in 2024.

| More on:

Tech stocks may be climbing back from bottoming out, but when it comes to software stocks there are still a lot of gains to be made. After so many cuts over the last year, looking ahead, these software stocks are looking quite undervalued. Profit is bound to come for many, but especially the three software stocks we’re going to cover today.

So if you’re looking for substantial growth not just this year, but for several years to come, definitely consider these three on the TSX today.

Dye & Durham

Dye & Durham (TSX:DND) was once a heavy hitter, seen as potentially a software stock with the most stable set of cashflows. The company provides its software to law firms, government agencies, charities and the like. These are often long-term contracts, offering stable cash flows.

Yet after increasing pricing by a substantial amount, one of the first tech stocks to do so, shares plunged. And since then, shares haven’t really recovered. DND stock now remains quite undervalued in the opinion of analysts. And investors should consider it once more.

In fact, DND stock recently reported it would be buying back shares at a price of $12.10 per share totalling $126 million. So management clearly believes DND stock can come back to greatness, with shares now at $13 as of writing. Analysts think even more is on the way, with DND stock holding a consensus price target of $23 as of writing. So certainly keep this software stock on your radar.

Kinaxis

Another software stock to consider is Kinaxis (TSX:KXS), with the supply-chain management software company also seeing shares collapse during the last few years. Yet the tech stock really didn’t deserve the drop, given that it operates with long-term contracts from some of the largest enterprise companies in the world.

In fact, the large majority of its revenue comes from subscriptions, with the rest from professional services. It’s also worth noting that Kinaxis stock was ahead of the curve when it came to implementing artificial intelligence (AI) into its business. The company’s RapidResponse program allows it to identify not just current issues for companies, but potential ones down the road.

Yet shares of Kinaxis stock remain undervalued, with shares at just $157 as of writing. Analysts now give it a consensus price target of $220 today. And this looks quite likely, as once inflation and interest rates go down and consumption goes up, the supply-chain company will need to be running on all cylinders.

OpenText

Finally, OpenText (TSX:OTEX) is another absolutely undervalued software stock. The company develops and sells enterprise information management software, and its future also lies within AI. The main purpose of the company is content and data management for large companies and government agencies. And it has become incredibly good at it, as many Canadian investors have seen over the years.

However, AI is about to create an even bigger opportunity for the stock. OpenText stock is now spending money on expanding its AI capabilities through several vectors it aims to launch over the next few years, with one already underway. Further, it is also spending on penetrating more of the U.S. market, where there is a large opportunity.

Yet again, OpenText stock is quite valuable. Cloud bookings rose, and over US$2 billion came in from selling part of its Micro Focus business. Yet the company still saw shares drop during its recent earnings report. This came from lower earnings before interest, taxes, depreciation and amortization (EBITDA), and no guidance increase.

Yet management states there will be an increase, and it wants to make sure it follows through with that guidance. Furthermore, buybacks are also in the near future. So with shares at $55 as of writing, and trading at 2 times sales, it’s definitely a software stock to have on the books.

Fool contributor Amy Legate-Wolfe has positions in Kinaxis. The Motley Fool recommends Kinaxis. The Motley Fool has a disclosure policy.

More on Tech Stocks

Rocket lift off through the clouds
Tech Stocks

2 Growth Stocks Set to Skyrocket in 2026 and Beyond

Growth stocks like Blackberry and Well Health Technologies are looking forward to leveraging strong opportunities in their respective industries.

Read more »

Happy golf player walks the course
Tech Stocks

The January Reset: 2 Beaten-Down TSX Stocks That Could Stage a Comeback

A January TFSA reset can work best with “comeback” stocks that still have real cash engines, not just hype.

Read more »

investor looks at volatility chart
Tech Stocks

1 Magnificent Canadian Tech Stock Down 38% to Buy and Hold for Decades

Constellation Software is a TSX tech stock that offers significant upside potential to shareholders over the next 12 months.

Read more »

AI concept person in profile
Tech Stocks

Tech’s January Bounce: 2 Canadian Stocks That Could Lead a 2026 Rebound

A January tech bounce can happen fast when fresh money and improving mood push investors back into overlooked Canadian names.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Stocks Retirees Should Absolutely Love

Discover strategies for managing stocks during retirement, especially in light of market uncertainties and downturns.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Down 38%, This Magnificent Canadian Stock Could Be the Biggest Bargain on the TSX Today

Constellation Software (TSX:CSU) was a tough hold in 2025, could the new year be a turning point.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Meet the Canadian Semiconductor Stock Up 150% This Year

Given its healthy growth outlook and reasonable valuation, 5N Plus would be a compelling buy at these levels.

Read more »

money goes up and down in balance
Tech Stocks

1 Magnificent Canadian Stock Down 26% to Buy and Hold Forever

Lightspeed isn’t the pandemic high-flyer anymore and that reset may be exactly what gives patient investors a better-risk, better-price entry…

Read more »